The story conflated Trump's criticisms of Ireland with long-held industry concerns over the PBS. There is a world of difference, given that Trump is following Obama to reverse the impact of Ireland's low tax rate on the pharma industry, and recent US administrations have shown more interest in adopting PBS policies than seeking their elimination.
In 2025, the US is more likely to adopt PBS pricing policies than oppose them
March 17, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Reform was justified because a committee prioritising clinical considerations was 'culturally' problematic
January 4, 2026 - - Latest News -
AdAlta and SHcell launch cancer collaboration to progress breakthrough CAR-T therapy
January 2, 2026 - - Australian Biotech -
Cabinet documents from the year that led to transformational changes
January 1, 2026 - - Latest News -
US pricing push gets real with Australia included in comparison list
December 22, 2025 - - Latest News -
Parsimony has unfortunately become an enduring test of the institution's legitimacy
December 20, 2025 - - Latest News -
PBAC delivers a broad range of outcomes in November, including for obesity
December 20, 2025 - - Latest News -
Takeda’s next-generation psoriasis therapy delivers landmark Phase 3 results
December 19, 2025 - - Latest News

